Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma(CNS Neuroscience & Therapeutics, (2020), 26, (1-10), 10.1111/cns.13227)

Jia Wang; Jie Zuo; Mao De Wang; Wan Fu Xie; Xiao Bin Bai; Xu Dong Ma

doi:10.1111/cns.13227

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma(CNS Neuroscience & Therapeutics, (2020), 26, (1-10), 10.1111/cns.13227)

Jia Wang
, Jie Zuo
, Mao De Wang
, Wan Fu Xie
, Xiao Bin Bai
, Xu Dong Ma

The First Affiliated Hospital of Xi’an Jiaotong University
The Second Affiliated Hospital of Xi'an Jiaotong University

科研成果: 期刊稿件 › 文章 › 同行评审

1 引用（Scopus）

摘要

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.

源语言	英语
页（从-至）	777
页数	1
期刊	CNS Neuroscience and Therapeutics
卷	26
期	7
DOI	https://doi.org/10.1111/cns.13227
出版状态	已出版 - 1 7月 2020
已对外发布	是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

可持续发展目标 3 良好健康与福祉

访问文件

10.1111/cns.13227

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{ddfab569f7744409885a5165642075bb,

title = "Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma(CNS Neuroscience \& Therapeutics, (2020), 26, (1-10), 10.1111/cns.13227)",

abstract = "Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience \& Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley \& Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.",

author = "Jia Wang and Jie Zuo and Wang, \{Mao De\} and Xie, \{Wan Fu\} and Bai, \{Xiao Bin\} and Ma, \{Xu Dong\}",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. CNS Neuroscience \& Therapeutics Published by John Wiley \& Sons Ltd.",

year = "2020",

month = jul,

day = "1",

doi = "10.1111/cns.13227",

language = "英语",

volume = "26",

pages = "777",

journal = "CNS Neuroscience and Therapeutics",

issn = "1755-5930",

publisher = "John Wiley and Sons Inc",

number = "7",

}

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma(CNS Neuroscience & Therapeutics, (2020), 26, (1-10), 10.1111/cns.13227). / Wang, Jia; Zuo, Jie; Wang, Mao De 等.
在: CNS Neuroscience and Therapeutics, 卷 26, 号码 7, 01.07.2020, 页码 777.

科研成果: 期刊稿件 › 文章 › 同行评审

TY - JOUR

T1 - Retraction

T2 - Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma(CNS Neuroscience & Therapeutics, (2020), 26, (1-10), 10.1111/cns.13227)

AU - Wang, Jia

AU - Zuo, Jie

AU - Wang, Mao De

AU - Xie, Wan Fu

AU - Bai, Xiao Bin

AU - Ma, Xu Dong

PY - 2020/7/1

Y1 - 2020/7/1

N2 - Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.

AB - Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.

UR - https://www.scopus.com/pages/publications/85073947172

U2 - 10.1111/cns.13227

DO - 10.1111/cns.13227

M3 - 文章

C2 - 31578804

AN - SCOPUS:85073947172

SN - 1755-5930

VL - 26

SP - 777

JO - CNS Neuroscience and Therapeutics

JF - CNS Neuroscience and Therapeutics

IS - 7

ER -

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma(CNS Neuroscience & Therapeutics, (2020), 26, (1-10), 10.1111/cns.13227)

摘要

联合国可持续发展目标

访问文件

其它文件与链接

学术指纹

引用此